These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 9218507)
1. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. LaFerla FM; Troncoso JC; Strickland DK; Kawas CH; Jay G J Clin Invest; 1997 Jul; 100(2):310-20. PubMed ID: 9218507 [TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity. de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696 [TBL] [Abstract][Full Text] [Related]
3. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA. Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways. O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019 [TBL] [Abstract][Full Text] [Related]
5. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition? Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195 [TBL] [Abstract][Full Text] [Related]
6. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan. Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330 [TBL] [Abstract][Full Text] [Related]
8. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4. Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099 [TBL] [Abstract][Full Text] [Related]
10. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937 [TBL] [Abstract][Full Text] [Related]
11. Roles for lipoprotein lipase in Alzheimer's disease: an association study. Baum L; Wiebusch H; Pang CP Microsc Res Tech; 2000 Aug; 50(4):291-6. PubMed ID: 10936883 [TBL] [Abstract][Full Text] [Related]
12. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
14. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Russo C; Angelini G; Dapino D; Piccini A; Piombo G; Schettini G; Chen S; Teller JK; Zaccheo D; Gambetti P; Tabaton M Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15598-602. PubMed ID: 9861015 [TBL] [Abstract][Full Text] [Related]
15. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. Frautschy SA; Horn DL; Sigel JJ; Harris-White ME; Mendoza JJ; Yang F; Saido TC; Cole GM J Neurosci; 1998 Oct; 18(20):8311-21. PubMed ID: 9763475 [TBL] [Abstract][Full Text] [Related]
16. ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer's disease. Mouchard A; Boutonnet MC; Mazzocco C; Biendon N; Macrez N; Sci Rep; 2019 Mar; 9(1):3989. PubMed ID: 30850702 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517 [TBL] [Abstract][Full Text] [Related]
18. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners? Kanekiyo T; Xu H; Bu G Neuron; 2014 Feb; 81(4):740-54. PubMed ID: 24559670 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients. Gómez-Ramos P; Mufson EJ; Morán MA Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]